Newman v. Bayer Corporation

CourtDistrict Court, S.D. New York
DecidedMarch 19, 2025
Docket7:22-cv-07087
StatusUnknown

This text of Newman v. Bayer Corporation (Newman v. Bayer Corporation) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Newman v. Bayer Corporation, (S.D.N.Y. 2025).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK

TANYSHA NEWMAN, individually and on behalf of all others similarly situated,

Plaintiff, No. 22-CV-7087 (KMK) v. OPINION & ORDER BAYER CORPORATION, and BAYER HEALTHCARE LLC,

Defendants.

Appearances:

L. Timothy Fisher, Esq. Bursor & Fisher, P.A. Walnut Creek, CA Counsel for Plaintiff

Max Stuart Roberts, Esq. Caroline Cella Donovan, Esq. Bursor & Fisher, P.A. New York, NY Counsel for Plaintiff

Jonathan F. Cohn, Esq. Shannon Grammel, Esq. Jacob B. Richards, Esq. Lehotsky Keller Cohn LLP Washington, DC Counsel for Defendants

Katherine Yarger, Esq. Lehotsky Keller Cohn LLP Denver, CO Counsel for Defendants

Alexis Swartz, Esq. Lehotsky Keller Cohn LLP Austin, TX Counsel for Defendants KENNETH M. KARAS, United States District Judge: Plaintiff Tanysha Newman (“Plaintiff”) brings this putative class action against Bayer Corporation and Bayer Healthcare, LLC (collectively, “Bayer” or “Defendants”), alleging that the labeling on Defendants’ “gummy” or “chewable” line of One A Day supplements (the “Product”) is deceptive and misleading. (See generally Compl. (Dkt. No. 1).) Plaintiff brings

claims for damages against Defendants for (1) common law breach of express warranty; (2) violation of the Magnuson-Moss Warranty Act, 15 U.S.C. §§ 2301, et seq., and (3) violations of Sections 349 and 350 of the New York General Business Law (“GBL”), N.Y. Gen. Bus. Law §§ 349, 350. (See id. ¶¶ 42–72.) Before the Court is Plaintiff’s Motion for Class Certification (the “Motion”), (Not. of Mot. (Dkt. No. 69)), and Defendants’ Objection to Magistrate Judge Krause’s Order Denying a Letter Motion to Compel Production (the “Objection”). For the foregoing reasons, Defendants’ Objection is overruled and Plaintiff’s Motion is granted. I. Background The Court assumes familiarity with the facts of this case and addresses only those

necessary to decide the instant Motion and Objection. Defendants sell a line of vitamin supplements under the “One A Day” brand. (See Compl. ¶¶ 1–2.) Plaintiff alleges that Defendants’ claim behind their One A Day line of supplements . . . that the consumer need only consume one supplement per day to get the full nutritional benefit . . . may be true of Defendants’ capsule supplements, [but] . . . is not true for their “gummies” or chewable line . . ., which require the consumer to take two or more supplements per day to get the full nutritional benefit. (Id. ¶ 1.) According to Plaintiff, consumers are misled by the Product’s front label packaging, which lists the number of gummies in each bottle and prominently displays the “One A Day” brand name. (See id. ¶¶ 3, 20–23.) On September 28, 2023, the Court granted in part and denied in part Defendant’s Motion to Dismiss; specifically, the Court granted the motion with respect to Plaintiff’s claim of common law fraud but denied the motion with respect to all other claims. (See Dkt. No. 27 at 25.) On July 19, 2024, Plaintiff filed the instant Motion for Class Certification. (See Not. of Mot.; Mem. in Supp. of Pl’s Mot. (“Pl’s Mem.”) (Dkt. No. 74); Decl. of Max S. Roberts (“Roberts Decl.”) (Dkt. No. 75); Decl. of Robert L. Klein (“Klein Rpt.”) (Dkt. No. 72); Decl. of Colin B. Weir (“Weir Decl.”) (Dkt. No. 76).) After an extension, (see Dkt. No. 79), Defendants

filed their Opposition on September 13, 2024. (See Mem. in Opp. to Pl’s Mot. (“Defs’ Opp.”) (Dkt. No. 85); Decl. of Jonathan F. Cohn (“Cohn Decl.”) (Dkt. Nos. 86–87).) On October 10, 2024, Plaintiff replied. (See Reply Mem. in Supp. of Pl’s Mot. (“Pl’s Reply”) (Dkt. No. 92); Rebuttal Decl. of Robert L. Klein (“Klein Rebuttal”) (Dkt. No. 94).) In the midst of briefing on class certification, the Parties engaged in a discovery dispute. Plaintiff retained an expert, Robert L. Klein, “to design, conduct, and analyze a market research survey to determine whether a significant number of the relevant consumers were misled by . . . Defendants’ One A Day name by understanding how many gummies they think are in a serving size.” (Klein Rpt. ¶ 11.) Klein and his team ran two surveys and Klein relied on the results of

the second survey to form the basis of his expert opinion. (See Mot. to Compel Order (Dkt. No. 99) 2.) Defendants discovered the existence of the first survey at Klein’s deposition, after which Plaintiff produced the first survey instrument and “top[-]line” figures but refused to produce the underlying responses and data. (See Dkt. No. 82 at 2.) On August 30, 2024, Defendants filed a letter Motion to Compel production of the responses to, and data from, the first survey. (See generally id.) The same day, Plaintiff responded in opposition. (See Dkt. No. 83.) On December 2, 2024, Judge Krause issued an order (the “Order”) denying Defendants’ Motion to Compel. (See Mot. to Compel Order.) On December 16, 2024, pursuant to Federal Rule of Civil Procedure 72(a), Defendants filed their Objection to the Order. (See Defs’ Objections to Non-Dispositive Order (“Defs’ Obj.”) (Dkt. No. 100).) On December 30, 2024, Plaintiff filed a response. (See Pl’s Resp. to Defs’ Obj. (“Pl’s Resp.”) (Dkt. No. 104).) On January 6, 2025, Defendants filed a reply. (See Defs’ Reply in Supp of Obj. (Dkt. No. 109).) II. Discussion A. Rule 72 Objection

Defendants object to the Order as contrary to Rule 26(a)(2). (See generally Defs’ Obj.) Plaintiff responds that the Order is not clearly erroneous and that her withholding of documents is in accordance with her discovery obligations. (See generally Pl’s Resp.) Defendants request that the Court set aside the Order, compel production of the first survey’s data and responses and the names of Klein’s employees who reviewed and tabulated that data, and permit Defendants to conduct a deposition. (Defs’ Obj. 16.) For the reasons discussed below, the Court overrules Defendants’ Objection. 1. Standard of Review “A district court reviewing a decision from a magistrate judge addressing a dispositive

motion ‘may accept, reject, or modify, in whole or in part, the findings or recommendations made by the magistrate judge.’” GlobalFoundries U.S. Inc. v. Int’l Bus. Machines Corp., No. 23-CV-3348, 2024 WL 4452146, at *2 (S.D.N.Y. Oct. 9, 2024) (quoting 28 U.S.C. § 636(b)(1)). However, “[u]nder Rule 72 of the Federal Rules of Civil Procedure, ‘when a pretrial matter not dispositive of a party’s claim or defense is referred to a magistrate judge to hear and decide,’ the district court ‘must consider timely objections and modify or set aside any part of the order that is clearly erroneous or is contrary to law.’” Michelo v. Nat’l Collegiate Student Loan Tr. 2007-2, Nos. 18-CV-1781, 18-CV-7692, 2022 WL 153183, at *2 (S.D.N.Y. Jan. 18, 2022) (alteration adopted). “Orders involving discovery are considered nondispositive.” Pac. Life Ins. Co. v. Bank of New York Mellon, 571 F. Supp. 3d 106, 112 (S.D.N.Y. 2021). “‘An order is clearly erroneous only when the reviewing court on the entire evidence is left with the definite and firm conviction that a mistake has been committed’ and is ‘contrary to law if it fails to apply or misapplies relevant statutes, case law[,] or rules of procedure.’” Id. (quoting Blackrock Allocation Target Shares: Series S. Portfolio v. Wells Fargo Bank, Nat’l Ass’n,

No. 14-CV-10067, 2018 WL 3863447, at *3 (S.D.N.Y. Aug. 13, 2018)) (internal quotation marks omitted).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Amchem Products, Inc. v. Windsor
521 U.S. 591 (Supreme Court, 1997)
Parker v. Time Warner Entertainment Co., L.P.
331 F.3d 13 (Second Circuit, 2003)
Comcast Corp. v. Behrend
133 S. Ct. 1426 (Supreme Court, 2013)
Catholic Healthcare West v. US Foodservice Inc.
729 F.3d 108 (Second Circuit, 2013)
Charron v. Wiener
731 F.3d 241 (Second Circuit, 2013)
Goshen v. Mutual Life Insurance
774 N.E.2d 1190 (New York Court of Appeals, 2002)
Oswego Laborers' Local 214 Pension Fund v. Marine Midland Bank, N. A.
647 N.E.2d 741 (New York Court of Appeals, 1995)
Koch v. ACKER, MERRALL & CONDIT COMPANY
967 N.E.2d 675 (New York Court of Appeals, 2012)
Vince Mullins v. Direct Digital, LLC
795 F.3d 654 (Seventh Circuit, 2015)
In re Mirena IUD Products Liability Litigation
169 F. Supp. 3d 396 (S.D. New York, 2016)
In re Namenda Direct Purchaser Antitrust Litig.
331 F. Supp. 3d 152 (S.D. Illinois, 2018)
Denney v. Deutsche Bank AG
443 F.3d 253 (Second Circuit, 2006)
Miles v. Merrill Lynch & Co.
471 F.3d 24 (Second Circuit, 2006)
Roach v. T.L. Cannon Corp.
778 F.3d 401 (Second Circuit, 2015)
Johnson v. Nextel Communications Inc.
780 F.3d 128 (Second Circuit, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
Newman v. Bayer Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/newman-v-bayer-corporation-nysd-2025.